Trial Condition(s):

Hypogonadism

Association between the Prevalence of cardiovascular risk factors and new use of testosterone

Bayer Identifier:

19547

ClinicalTrials.gov Identifier:

NCT03484260

EudraCT Number:

Not Available

Study Completed

Trial Purpose

We will investigate if testosterone is preferentially given to patients at higher risk of cardiovascular events. If this is the case, then observational studies may be prone to selection bias resulting in overestimation of the cardiovascular risk associated with testosterone when compared to a healthier population not taking testosterone

Inclusion Criteria
- All male individuals in the source population with a first testosterone use during the study period will be included as cases. The date of the GP consultation associated with the first testosterone prescription will be designated as the index day.
Exclusion Criteria
- Patients of less than 18 years on the index day, with less than 2-year contribution to the CPRD-HES link before the index day, or with use of testosterone before the study period will be excluded from the group of cases.

Trial Summary

Enrollment Goal
27778
Trial Dates
black-arrow
Phase
4
Could I receive a placebo?
No
Products
Unspecified
Accepts Healthy Volunteers
No

Where to Participate

Loading...
Locations
Status
LocationsStatus
Locations

Many Locations

Berlin, Germany, 13342

Status
Completed
 

Trial Design